Jumar Masterclass - Scaling Your Biotech Team: Smart Hiring Strategies in Challenging Financial Times

For small to medium-sized biotech companies, scaling isn’t just about advancing the science — it’s about building and nurturing a team that can deliver on your vision. In an environment where funding is competitive and resources are tight, making smart, strategic hiring decisions is crucial.

We’ll explore practical ways to align hiring with your company’s growth stage, examine the benefits and trade-offs of sourcing talent locally versus internationally, and discuss when it’s better to invest in permanent hires versus contractors or consultants. You’ll also hear how to safeguard your culture, navigate hiring challenges, and build resilience into your workforce strategy.

You’ll leave this session with:

• Practical ideas for aligning hiring with growth stage and immediate priorities

• Clarity on the pros and cons of hiring locally versus internationally

• Examples of cost-effective and flexible workforce models in resource-limited settings

• Insights from industry leaders on building and retaining the right team for scale

• A shortlist of actionable steps to strengthen your hiring strategy

NOTE: You may be photographed or videod while attending this event for marketing purposes: please approach the organiser if you have questions, concerns, or do not wish this to happen.

The masterclass will be followed by an optional tour of Jumar Bioincubator. Let us know in the registration form if you're interested in participating.

==

About 

Jumar Bioincubator serves as a ‘first home’ for 30+ biotech ventures in Australia, providing affordable lab and office space alongside practical support to advance early scientific discoveries. Residents gain access to world-class facilities, a dedicated support team, and curated entrepreneurial training and events.

Established by CSL, WEHI and the University of Melbourne, and backed by Breakthrough Victoria with Cicada Innovations as operator, Jumar’s mission is to connect early-stage and scaling biotech ventures with the support needed to translate discoveries into real-world therapies and build a community of scientists equipped to lead successful biomedical ventures.